Feasibility study of conformal forward planned simultaneous integrated boost technique comparable to IMRT and VMAT in pelvic irradiation for locally advanced cervical cancer

[1] Choy D, Wong LC, Sham J, et al. Dose-tumor response of carcinoma of cervix: an analysis of 594 patients treated by radiotherapy. Gynecol Oncol. 1993;49(3):311-17.10.1006/gyno.1993.1132Search in Google Scholar

[2] Lanciano RM, Martz K, Coia LR, et al. Tumor and treatment factors improving outcome in stage III-B cervix cancer. Int J Radiat Oncol Biol Phys. 1991;20(1):95-100.10.1016/0360-3016(91)90143-RSearch in Google Scholar

[3] Niibe Y, Hayakawa K, Kanai T, et al. Optimal dose for stage IIIB adeno-carcinoma of the uterine cervix on the basis of biological effective dose. Eur J Gynaecol Oncol. 2006;27(1):47-9Search in Google Scholar

[4] Lanciano RM, Won M, Coia LR, et al. Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix: a final report of the 1973 and 1978 patterns of care studies. Int J Radiat Oncol Biol Phys. 1991;20(4):667-676.10.1016/0360-3016(91)90007-QSearch in Google Scholar

[5] Cihoric N, Tsikkinis A, Tapia C, et al. Dose escalated intensity modulated radiotherapy in the treatment of cervical cancer. Radiat Oncol. 2015;10:24010.1186/s13014-015-0551-0465724626597282Search in Google Scholar

[6] Beadle BM, Jhingran A, Salehpour M, et al. Cervix regression and motion during the course of external beam chemoradiation for cervical cancer. Int J Radiat Oncol Biol Phys. 2009;73(1):235-241.10.1016/j.ijrobp.2008.03.06418513882Search in Google Scholar

[7] Vandecasteele K, De Neve W, De Gersem W, et al. Intensity-modulated arc therapy with simultaneous integrated boost in the treatment of primary irresectable cervical cancer. Strahlenther Onkol. 2009;185(12):799-807.10.1007/s00066-009-1986-820013089Search in Google Scholar

[8] Kathirvel M, Subramanian S, Clivio A, et al. Critical appraisal of the accuracy of Acuros-XB and Anisotropic Analytical Algorithm compared to measurement and calculations with the compass system in the delivery of RapidArc clinical plans. Radiat Oncol. 2013;8:140.10.1186/1748-717X-8-140370245023758728Search in Google Scholar

[9] Fogliata A, Nicoloni G, Clivio A, et al. Dosimetric evaluation of Acuros XB Advanced Dose Calculation algorithm in heterogeneous media. Radiat Oncol. 2011;6:8210.1186/1748-717X-6-82316841121771317Search in Google Scholar

[10] Bush K, Gagne IM, Zavgorodni S, et al. Dosimetric validation of Acuros® XB with Monte Carlo methods for photon dose calculations. Med Phys. 2011;38(4):2208-2221.10.1118/1.356714621626955Search in Google Scholar

[11] Han T, Mikell JK, Salehpour M, et al. Dosimetric comparison of Acuros XB deterministic radiation transport method with Monte Carlo and model-based convolution methods in heterogeneous media. Med Phys. 2011;38(5):2651-2664.10.1118/1.3582690310783121776802Search in Google Scholar

[12] Han T, Mourtada F, Kisling K, et al. Experimental validation of deterministic Acuros XB algorithm for IMRT and VMAT dose calculations with the Radiological Physics Centre’s head and neck phantom. Med Phys. 2012;39(4):2193-2202.10.1118/1.3692180Search in Google Scholar

[13] Shaw E, Kline R, Gillin M, et al. Radiation therapy oncology group: Radiosurgery quality assurance guidelines. Int J Radiat Oncol Biol Phys. 1993;27(5):1231-1239.10.1016/0360-3016(93)90548-ASearch in Google Scholar

[14] Aly MOMA, Glatting G, Jahnke L, et al. Comparison of breast simultaneous integrated boost (SIB) radiotherapy techniques. Radiat Oncol. 2015;10:139.10.1186/s13014-015-0452-2Search in Google Scholar

[15] Cilla S, Deodato F, Digesù C, et al. Assessing the feasibility of volumetric modulated arc therapy using simultaneous integrated boost (SIB-VMAT): An analysis for complex head-neck, high risk prostate and rectal cancer cases. Med Dosim. 2014;39(1):108-116.10.1016/j.meddos.2013.11.001Search in Google Scholar

[16] Yang W, Jones R, Read P, et al. Standardized evaluation of simultaneous integrated boost plans on volumetric modulated arc therapy. Phys Med Biol. 2011;56(2):327-339.10.1088/0031-9155/56/2/003Search in Google Scholar

[17] van’t Riet A, Mak AC, Moerland MA, et al. A conformation number to quantify the degree of Conformality in brachytherapy and external beam Irradiation: application to the prostate. Int J Radiat Oncol Biol Phys. 1997;37(3):731-736.10.1016/S0360-3016(96)00601-3Search in Google Scholar

[18] Gay HA, Niemierko A. A free program for calculating EUD based NTCP and TCP in external beam radiotherapy. Phys Med. 2007;23(3-4):115-125.10.1016/j.ejmp.2007.07.001Search in Google Scholar

[19] Okunieff P, Morgan D, Niemierko A, et al. Radiation dose-response of human tumors. Int J Radiat Oncol Biol Phys. 1995;32(4):1227-1237.10.1016/0360-3016(94)00475-ZSearch in Google Scholar

[20] Suit H, Skates S, Taghian A, et al. Clinical implications of heterogeneity of tumor response to radiation therapy. Radiother Oncol. 1992;25(4):251-260.10.1016/0167-8140(92)90244-OSearch in Google Scholar

[21] Girinsky T, Rey A, Roche B, et al. Overall treatment time in advanced cervical carcinomas: a critical parameter in treatment outcome. Int J Radiat Oncol Biol Phys. 1993;27(5):1051-1056.10.1016/0360-3016(93)90522-WSearch in Google Scholar

[22] Lanciano RM, Pajak TF, Martz K, et al. The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: a patterns-of-care study. Int J Radiat Oncol Biol Phys. 1993;25(3):391-397.10.1016/0360-3016(93)90058-4Search in Google Scholar

[23] Sugawara T, Mizutani Y, Nakazawa M, et al. The effect of treatment time on pelvic recurrence in patients with stage III-IV uterine cervix cancer. J Jpn Soc Ther Radiol Oncol. 1993;5:117-123.Search in Google Scholar

[24] Perez CA, Grigsby PW, Castro-Vita H, et al. Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy. Int J Radiat Oncol Biol Phys. 1995;32(5):1275-1288.10.1016/0360-3016(95)00220-SSearch in Google Scholar

[25] Nishimura Y, Okajima K, Hiraoka M. Optimal overall treatment time in fractionated radiotherapy for head and neck cancers, esophageal cancer, and uterine cervical cancer. Nippon Hoshasen Shuyo Gakkai-Shi. 1996;8(4):303-315.Search in Google Scholar

[26] Withers HR, Taylor JM, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol. 1988;27(2):131-146.10.3109/02841868809090333Search in Google Scholar

[27] Petereit DG, Sarkaria JN, Chappell R, et al. The adverse effect of treatment prolongation in cervical carcinoma. Int J Radiat Oncol Biol Phys. 1995;32(5):1301-1307.10.1016/0360-3016(94)00635-XSearch in Google Scholar

[28] Fyles AW, Pintilie M, Kirkbride P, et al. Prognostic factors in patients treated cervix cancer treated by radiation therapy: results of multiple regression analysis. Radiotherapy Oncol.1995;35(2):107-117.10.1016/0167-8140(95)01535-OSearch in Google Scholar

[29] Wu Q, Manning M, Schmidt-Ullrich R, et al. The potential for sparing of parotids and escalation of biologically effective dose with intensity-modulated radiation treatments of head and neck cancers: a treatment design study. Int J Radiat Oncol Biol Phys. 2000;46(1):195-205.10.1016/S0360-3016(99)00304-1Search in Google Scholar

[30] Bos LJ, Damen EM, de Boer RW, et al. Reduction of rectal dose by integration of the boost in the large-field treatment plan for prostate irradiation. Int J Radiat Oncol Biol Phys. 2002;52(1):254-265.10.1016/S0360-3016(01)02676-1Search in Google Scholar

[31] Vandecasteele K, De Neve W, De Gersem W, et al. Intensity modulated arc therapy with simultaneous integrated boost in the treatment of primary irresectable cervical cancer. Treatment planning, quality control, and clinical implementation. Strahlenther Onkol. 2009;185(12):799-807.10.1007/s00066-009-1986-8Search in Google Scholar

[32] Dogan N, King S, Emami B, et al. Assessment of different IMRT boost delivery methods on target coverage and normal tissue sparing. Int J Radiat Oncol Biol Phys. 2003;57(5):1480-1491.10.1016/S0360-3016(03)01569-4Search in Google Scholar

[33] Fogliata A, Bolsi A, Cozzi L, et al. Comparative dosimetric evaluation of the simultaneous integrated boost with photon intensity modulation in head and neck cancer patients. Radiother Oncol. 2003;69(3):267-275.10.1016/j.radonc.2003.10.00314644486Search in Google Scholar

[34] Mohan R, Wu Q, Manning M, et al. Radiobiological considerations in the design of fractionation strategies for intensity-modulated radiation therapy of head and neck cancers. Int J Radiat Oncol Biol Phys. 2000;46(3):619-630.10.1016/S0360-3016(99)00438-1Search in Google Scholar

[35] Haque WM, Endres EC, Szeja S, et al. Simultaneous Integrated Boost using Conformal Radiation Therapy for Treatment of Cervical Cancer. Intl J Cancer Oncol. 2016;3(1):1-7.10.15436/2377-0902.16.802Search in Google Scholar